H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial-Reference-Cited by-同舟云学术

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

Published:2016-03 Issue:3 Volume:16 Page:303-310
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Rudenko Larisa,Isakova-Sivak Irina,Naykhin Anatoly,Kiseleva Irina,Stukova Marina,Erofeeva Mariana,Korenkov Daniil,Matyushenko Victoria,Sparrow Erin,Kieny Marie-Paule

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference32 articles.

1. Epidemiology, evolution, and recent outbreaks of avian influenza virus in China;Su;J Virol,2015

2. Transmission potential of influenza A(H7N9) virus, China, 2013–2014;Kucharski;Emerg Infect Dis,2015

3. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses;Shi;Science,2013

4. Biological features of novel avian influenza A (H7N9) virus;Zhou;Nature,2013

5. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice;Belser;Nature,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conserved linear B-cell peptides among the influenza A viral neuraminidases enhance the cross-protective potential of inactivated whole-virion influenza vaccine;Russian Journal of Infection and Immunity;2024-07-28

2. Pandemic preparedness through vaccine development for avian influenza viruses;Human Vaccines & Immunotherapeutics;2024-05-28

3. In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19;Vaccines;2022-09-16

4. Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years;Pharmaceuticals;2022-09-09

5. Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector;Vaccines;2022-07-18